# Efficacy of melanoma patients treated with PD-1 inhibitors Protocol for an overview, and a network meta-analysis of randomized controlled trials

CorpusID: 195812117 - [https://www.semanticscholar.org/paper/64765d281e82403aec7c57736e8694ea674d6ebd](https://www.semanticscholar.org/paper/64765d281e82403aec7c57736e8694ea674d6ebd)

Fields: Medicine

## (s2) Study methods and analysis
Number of References: 2

(p2.0) This protocol will be performed in accordance with recommendations of "Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols" (PRISMA-P) statement guidelines. A study [10] has shown that prospective registration can effectively improve the overall methodological quality of SRs, so current study has been registered on the International prospective register of systematic reviews (PROSPERO), the registration number is CRD42019120017, Available from http://www.crd.york.ac.uk/ PROSPERO/display_record.php?ID=CRD42019120017 This is an overview and a NMA based on published studies; therefore, ethical approval is not required.
## (s6) Assessment of risk of bias of included RCTs in identified SRs
Number of References: 2

(p6.0) For each embedded RCTs, their risks of bias will be assessed by the Cochrane's risk of bias tool. [16] The evaluation tool includes 6 aspects:
## (s17) Study methods and analysis
Number of References: 2

(p17.0) This protocol will be performed in accordance with recommendations of "Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols" (PRISMA-P) statement guidelines. A study [10] has shown that prospective registration can effectively improve the overall methodological quality of SRs, so current study has been registered on the International prospective register of systematic reviews (PROSPERO), the registration number is CRD42019120017, Available from http://www.crd.york.ac.uk/ PROSPERO/display_record.php?ID=CRD42019120017 This is an overview and a NMA based on published studies; therefore, ethical approval is not required.
## (s21) Assessment of risk of bias of included RCTs in identified SRs
Number of References: 2

(p21.0) For each embedded RCTs, their risks of bias will be assessed by the Cochrane's risk of bias tool. [16] The evaluation tool includes 6 aspects:
